Dr. Gina Keiffer, MD
Claim this profileSidney Kimmel Cancer Center at Thomas Jefferson University
Area of expertise
Acute Myeloid Leukemia
Gina Keiffer, MD has run 4 trials for Acute Myeloid Leukemia. Some of their research focus areas include:
Relapse
Gina Keiffer, MD has run 3 trials for Relapse. Some of their research focus areas include:
Affiliated Hospitals
Sidney Kimmel Cancer Center At Thomas Jefferson University
Thomas Jefferson University Hospital
Clinical Trials Gina Keiffer, MD is currently running
DSP-5336
for Leukemia
This trial is testing a new drug called DSP 5336 to help treat adults with certain types of blood cancer that have come back or didn't respond to previous treatments. The study will first find the best amount to give and then check how safe and helpful it is.
Recruiting
1 award
Phase 1 & 2
15 criteria
Venetoclax + Obinutuzumab
for Leukemia
This phase III trial compares early treatment with venetoclax and obinutuzumab versus delayed treatment with venetoclax and obinutuzumab in patients with newly diagnosed high-risk chronic lymphocytic leukemia or small lymphocytic lymphoma. Venetoclax is in a class of medications called B-cell lymphoma-2 (BCL-2) inhibitors. It may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Immunotherapy with monoclonal antibodies, such as obinutuzumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Starting treatment with the venetoclax and obinutuzumab early (before patients have symptoms) may have better outcomes for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma compared to starting treatment with the venetoclax and obinutuzumab after patients show symptoms.
Recruiting
2 awards
Phase 3
1 criteria
More about Gina Keiffer, MD
Clinical Trial Related
2 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Gina Keiffer, MD has experience with
- Venetoclax
- Liposome-encapsulated Daunorubicin-Cytarabine
- Palbociclib
- Tazemetostat
- Capecitabine
- CYT-0851
Breakdown of trials Gina Keiffer, MD has run
Acute Myeloid Leukemia
Relapse
Non-Hodgkin's Lymphoma
Chronic Lymphocytic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Gina Keiffer, MD specialize in?
Gina Keiffer, MD focuses on Acute Myeloid Leukemia and Relapse. In particular, much of their work with Acute Myeloid Leukemia has involved FLT3 positive patients, or patients who are NPM1 positive.
Is Gina Keiffer, MD currently recruiting for clinical trials?
Yes, Gina Keiffer, MD is currently recruiting for 2 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Gina Keiffer, MD has studied deeply?
Yes, Gina Keiffer, MD has studied treatments such as Venetoclax, Liposome-encapsulated Daunorubicin-Cytarabine, Palbociclib.
What is the best way to schedule an appointment with Gina Keiffer, MD?
Apply for one of the trials that Gina Keiffer, MD is conducting.
What is the office address of Gina Keiffer, MD?
The office of Gina Keiffer, MD is located at: Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania 19107 United States. This is the address for their practice at the Sidney Kimmel Cancer Center at Thomas Jefferson University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.